Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O43497: Variant p.Arg1715His

Voltage-dependent T-type calcium channel subunit alpha-1G
Gene: CACNA1G
Feedback?
Variant information Variant position: help 1715 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Histidine (H) at position 1715 (R1715H, p.Arg1715His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In SCA42; changed voltage-gated calcium channel activity; membrane potential dependency is shifted toward more positive potentials. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 1715 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2377 The length of the canonical sequence.
Location on the sequence: help IEVNASLPINPTIIRIMRVL R IARVLKLLKMAVGMRALLDT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         IEVNASLPINPTIIRIMRVLRIARVLKLLKMAVGMRALLDT

Rat                           IEVNLSLPINPTIIRIMRVLRIARVLKLLKMAVGMRALLHT
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 2377 Voltage-dependent T-type calcium channel subunit alpha-1G
Transmembrane 1708 – 1731 Helical; Name=S4 of repeat IV
Repeat 1596 – 1854 IV
Glycosylation 1698 – 1698 N-linked (GlcNAc...) asparagine
Helix 1715 – 1722



Literature citations
A recurrent mutation in CACNA1G alters Cav3.1 T-type calcium-channel conduction and causes autosomal-dominant cerebellar ataxia.
Coutelier M.; Blesneac I.; Monteil A.; Monin M.L.; Ando K.; Mundwiller E.; Brusco A.; Le Ber I.; Anheim M.; Castrioto A.; Duyckaerts C.; Brice A.; Durr A.; Lory P.; Stevanin G.;
Am. J. Hum. Genet. 97:726-737(2015)
Cited for: INVOLVEMENT IN SCA42; VARIANT SCA42 HIS-1715; CHARACTERIZATION OF VARIANT SCA42 HIS-1715; FUNCTION; TRANSPORTER ACTIVITY; A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia.
Morino H.; Matsuda Y.; Muguruma K.; Miyamoto R.; Ohsawa R.; Ohtake T.; Otobe R.; Watanabe M.; Maruyama H.; Hashimoto K.; Kawakami H.;
Mol. Brain 8:89-89(2015)
Cited for: INVOLVEMENT IN SCA42; VARIANT SCA42 HIS-1715; CHARACTERIZATION OF VARIANT SCA42 HIS-1715; FUNCTION; SUBCELLULAR LOCATION; TRANSPORTER ACTIVITY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.